Trendlines Group Ltd.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Semi-annual Revenue
•
in mil. unless spec.Semi-annual Earnings Per Share
•
in mil. unless spec.Semi-annual Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Haim Brosh
- Full Time Employees
- 20
- Sector
- Finance
- Industry
- Investment managers
- Address
- Misgav Business Park Misgav HZ Israel 2017400
- IPO Date
- Nov 26, 2015
- Website
- trendlines.com
- Similar Companies
- Business
- The Trendlines Group Ltd. The Trendlines Group Ltd. is an Israel-based life sciences innovation commercialization company that invents, discovers, invests in, partners with, and incubates early-stage medical technologies (medtech) and agrifood technologies; it operates principally through four business units including Israeli government-franchised incubators Trendlines Medical and Trendlines Agtech, a Singapore incubator Trendlines Medical Singapore, and an in-house innovation center Trendlines Labs. The company maintains a portfolio of more than 50 companies focused on medtech areas such as cardiology, neurology and anesthesia, esthetics, gastroenterology, home healthcare, spine and orthopedics, surgery, urology and women's health; and agrifood areas including aquaculture and animal health, crop protection, digitization and robotics, future food and ingredients, and net-zero technologies, with representative portfolio companies encompassing AgroScout (AI-driven crop disease detection), Phytolon (natural food colors from yeast fermentation), Escala Medical (non-surgical pelvic organ prolapse repair), Vensica Medical (overactive bladder treatment), and EcoPhage (phage-based crop protection). Founded in 1993 and headquartered at 17 T’chelet Street in M.P. Misgav, Israel, with additional offices in Tel Aviv, Israel; Singapore; and formerly Beijing, China, the group provides comprehensive support to its portfolio companies encompassing technology development, business building, funding strategies, market commercialization, and administrative services while targeting entrepreneurs, inventors, investors, strategic partners, and governments primarily in Israel and Singapore. Recent developments include portfolio company Escala Medical securing $4.5 million in funding co-financed by the EIC Fund in June 2025 to expand its FDA-approved Mendit device for women's health; IBI Ag raising $6.1 million in initial Series A funding led by Corteva in 2025; Arcuro Medical closing an initial Series A round led by Varana Capital with Trendlines participation; ElastiMed appointing medical device veteran Dr. Amir Belson to its board amid commercialization preparations; and Vensica Medical raising $11 million led by Israel Biotech Fund to advance Phase 2 trials for overactive bladder therapy, alongside ongoing exits such as the prior acquisitions of OrthoSpin by DePuy Synthes (Johnson & Johnson) in November 2021 and ApiFix by OrthoPediatrics Corp. in 2020.
Company News
NICE Surgical Awarded Additional Purse-String Stapler Associated U.S. Patent
NICE Surgical Awarded U.S. Patent for Purse-String Stapler
2 Trendlines in Focus For Pfizer Stock After Earnings
IBI Ag Announces Successful Development of AI-Driven De Novo Protein Design Platform for Bioinsecticides
Key Trendlines to Watch After S&P 500's New Records
Natural Gas and Oil Forecast: Rally Extends, but Descending Trendlines Cap Upside Potential
S&P 500 Trendlines to Watch as Bulls Remain in Control
IBI Ag Completes $10 Million Series A Round Led by Corteva
Natural Gas and Oil Forecast: OPEC+ Hike and Trendlines Signal Further Weakness
Escala Secures $4.5M in Funding to Accelerate Global Expansion of Its FDA-Approved Medical Device
Why Nvidia Stock Woos Investors With Trendlines, Not Headlines
Natural Gas and Oil Forecast: Trendlines Hold as Traders Eye $3.76 and $63.86
Sprouts Farmers Market Stock Nears 2 Bullish Trendlines
3 Resistance Trendlines Driving the S&P 500's Advance
Arcuro Medical Announces FDA 510(k) Clearance for the SuperBall RC for Rotator Cuff Indications
Limaca's Precision-GI™ Enters US Market
IBI Ag Secures $6.1 Million in Funding Round Led by Corteva Inc.
Varana Capital Leads Arcuro Medical's Series A Financing, Driving Strategic Growth in 2025
GE Aerospace Stock Could Bounce Off Bullish Trendlines
Limaca's Precision-GI™ Granted CMS Transitional Pass-Through (TPT) Payment